Literature DB >> 16761158

Pain after elective arthroscopy of the knee: a prospective, randomised, study comparing conventional NSAID to coxib.

Eva Jacobson1, Hamid Assareh, Ronnie Cannerfelt, Per Renström, Jan Jakobsson.   

Abstract

Although outpatient knee arthroscopy is probably by far the most frequently performed orthopaedic procedure, there are limited guidelines or consensus concerning the peroral postoperative pain management. A diversity of analgesics both in potency and action is prescribed. The purpose of the present investigation was to grade the pain and need for rescue medication during the first 4 days after the knee arthroscopy, comparing a conventional nonsteroidal anti-inflammatory drug (NSAID) with a selective cox-II-inhibitor (coxib) as postoperative pain medication. One hundred and twenty-two patients scheduled for primary elective knee arthroscopy in general anaesthesia were randomised to either a NSAID (lornoxicam) or a selective cox-II-inhibitor (rofecoxib) postoperatively. Pain ratings and the need for rescue medication were followed for four consecutive days. Side effects were also registered. The need for rescue analgesics was highest the evening after surgery, when 42% of patients required one, or more, oral additional analgesics. The use of rescue medication decreased with time and 30, 25, 16 and 11% of the patients required additional analgesics for day 1 to 4, respectively, still 50% of all patients required at some point one or more rescue analgesics. Overall pain ratings were low, and showed similar pattern with evening and day, 50% of all patients required at some point one or more rescue analgesics. We found, however, no differences in pain ratings, or need for rescue analgesics between the two groups, conventional NSAID and coxib as well as no difference in side-effect profile. In conclusion, patients do require proper pain management also after minor outpatient surgical procedures such as knee arthroscopy. The traditional NSAIDs seem to be the first choice for analgesic and anti-inflammatory effects, when needed after elective arthroscopy of the knee.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16761158     DOI: 10.1007/s00167-006-0081-2

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  25 in total

1.  COX-2 selective inhibitors: a literature review of analgesic efficacy and safety in oral-maxillofacial surgery.

Authors:  Andrea Cicconetti; Adriano Bartoli; Francesca Ripari; Andrea Ripari
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  2004-02

2.  Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery.

Authors:  Nancy A Nussmeier; Andrew A Whelton; Mark T Brown; Richard M Langford; Andreas Hoeft; Joel L Parlow; Steven W Boyce; Kenneth M Verburg
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

3.  Cardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial.

Authors:  Robert S Bresalier; Robert S Sandler; Hui Quan; James A Bolognese; Bettina Oxenius; Kevin Horgan; Christopher Lines; Robert Riddell; Dion Morton; Angel Lanas; Marvin A Konstam; John A Baron
Journal:  N Engl J Med       Date:  2005-02-15       Impact factor: 91.245

4.  Cyclo-oxygenase-2 inhibitors : beneficial or detrimental for athletes with acute musculoskeletal injuries?

Authors:  Stuart J Warden
Journal:  Sports Med       Date:  2005       Impact factor: 11.136

5.  Postoperative analgesia and vomiting, with special reference to day-case surgery: a systematic review.

Authors:  H J McQuay; R A Moore
Journal:  Health Technol Assess       Date:  1998       Impact factor: 4.014

6.  Rofecoxib versus codeine/acetaminophen in postoperative dental pain: a double-blind, randomized, placebo- and active comparator-controlled clinical trial.

Authors:  D J Chang; J R Fricke; S R Bird; N R Bohidar; T W Dobbins; G P Geba
Journal:  Clin Ther       Date:  2001-09       Impact factor: 3.393

7.  Upper gastrointestinal safety evaluation of parecoxib sodium, a new parenteral cyclooxygenase-2-specific inhibitor, compared with ketorolac, naproxen, and placebo.

Authors:  S I Harris; M Kuss; R C Hubbard; J L Goldstein
Journal:  Clin Ther       Date:  2001-09       Impact factor: 3.393

8.  Comparison of rofecoxib and oxycodone plus acetaminophen in the treatment of acute pain: a randomized, double-blind, placebo-controlled study in patients with moderate to severe postoperative pain in the third molar extraction model.

Authors:  Scott Korn; Theodore C Vassil; Paul N-A Kotey; James R Fricke
Journal:  Clin Ther       Date:  2004-05       Impact factor: 3.393

Review 9.  Systematic review of the analgesic efficacy and tolerability of COX-2 inhibitors in post-operative pain control.

Authors:  L-C Chen; R A Elliott; D M Ashcroft
Journal:  J Clin Pharm Ther       Date:  2004-06       Impact factor: 2.512

Review 10.  Selecting new drugs for pain control: evidence-based decisions or clinical impressions?

Authors:  Arthur H Jeske
Journal:  J Am Dent Assoc       Date:  2002-08       Impact factor: 3.634

View more
  2 in total

1.  Lornoxicam injection is inferior to betamethasone in the treatment of subacromial impingement syndrome : A prospective randomized study of functional outcomes.

Authors:  M Aksakal; C Ermutlu; G Özkaya; Y Özkan
Journal:  Orthopade       Date:  2017-02       Impact factor: 1.087

2.  The effectiveness of traditional Chinese medicine fumigation and washing nursing care after arthroscopic debridement of Knee Osteoarthritis: A protocol for systematic review and meta-analysis.

Authors:  Honghong Cui; Yanxia Zhao; Chunmei Ju; Jixiu Hao
Journal:  Medicine (Baltimore)       Date:  2021-03-19       Impact factor: 1.817

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.